The author of that SA article sounded like an amateur, but that isn’t a surprise with SA.
My best guess would be that the US institutional investors get tapped next. They set up that avenue last year.
I also beleive this because SI has indicated that he doesn’t want to partner the paediatric aGVHD program- which is what the phase 3 trial was for.
Instead he wants to partner the adult aGVHD, class 2/3 CHF (not class 4), RA and chronic lower back pain programs.
There does appear to be a strong shift in sentiment after the phase 3 success though, so you could be right- that may be the catalyst to CHF or chronic lower back pain getting over the line.
So I would be very happy to be proven wrong
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-158
-
- There are more pages in this discussion • 17,701 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
88.5¢ |
Change
-0.085(8.76%) |
Mkt cap ! $1.010B |
Open | High | Low | Value | Volume |
95.0¢ | 95.0¢ | 88.0¢ | $9.657M | 10.58M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 140818 | 88.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
89.0¢ | 3680 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 135148 | 0.880 |
5 | 145397 | 0.875 |
6 | 78456 | 0.870 |
2 | 37505 | 0.865 |
5 | 79405 | 0.860 |
Price($) | Vol. | No. |
---|---|---|
0.890 | 3680 | 1 |
0.900 | 57718 | 5 |
0.905 | 31718 | 2 |
0.910 | 48808 | 3 |
0.915 | 133252 | 3 |
Last trade - 16.10pm 05/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |